Monday, 26 October 2015

Weakness In Biotech Sector Spreads As Valeant Continues To Defend Itself

The Wall Street Journal reports that the drug maker Valeant, already under scrutiny for its use of specialty pharmacies to distribute its drugs, placed employees at the specialty pharmacy, Philidor Rx Services, but their role was not always clear to other workers. Meanwhile, the drug company held a conference call to address questions raised about its business practices and to announce a committee to review the allegations.

No comments:

Post a Comment